ArmaVir Partners

CALDER GROUP provides precision engineering, nuclear engineering, lead engineered products, and bronze engineered products. They also provide aerospace and defence, construction, healthcare, marine, nuclear, oil and gas, security, and other markets.

PAX Labs is a leader in the design and development of premium, app-controlled vaporization technologies and devices. Headquartered in San Francisco, PAX has become an industry leader through innovation and product design. PAX is committed to taking the guesswork out of cannabis with products that offer quality, transparency, and predictability. The company was founded in 2007 and based in San Francisco, California.

NJOY is a trading name of NJOY, LLC, an independent American company that manufactures and distributes electronic cigarettes and vaping products. With offices located in New York City and Arizona, NJOY is a pioneer in vaping and a leader in a revolution against combustible cigarettes. The brand was founded in 2007 and has continued to serve as the innovation and thought leader in the vaping category, which is experiencing significant growth. NJOY products are sold in all 50 states in the United States. NJOY markets its products online; and through a network of retail stores, convenience stores, and dealers in the United States.

Bluebird bio is a clinical-stage biotechnology company that develops gene therapies for severe genetic and rare diseases. The company's gene therapy procedures aim to genetically modify a patient's cells to fundamentally correct or address the genetic basis underlying a disease. Bluebird's revenue is derived from collaboration arrangements, research fees, license fees, and grant revenue. The company works with industry peers, strategic partners, and nonprofit organizations for the development and commercialization of its product candidates.

Cascadian Therapeutics, a clinical-stage biopharmaceutical company, researches and develops, and sells therapeutic products for the treatment of cancer in the United States. The company lead clinical-stage product candidate is tucatinib, an orally active and HER2-selective small molecule tyrosine kinase inhibitor, which is in two Phase Ib trials, one in combination with Kadcyla and another in combination with Xeloda and/or Herceptin. It is also developing Checkpoint kinase 1, a protein kinase that is in pre-clinical studies to regulate the cell division cycle, as well as to DNA damage and replication stress. In addition, the company focuses on the development of novel antibodies and T-cell immunoreceptor with Ig and ITM domains, an inhibitory receptor expressed on T-cells and NK cells that negatively regulate immune response to cancers. It has a license agreement with Array BioPharma Inc. to develop, manufacture and commercialize tucatinib; research collaboration agreement with Sentinel Oncology Ltd. for the discovery of novel Chk1 inhibitors; and collaboration agreement with Adimab LLC for the discovery of novel antibodies against d immunotherapy targets in oncology.

Biomoda, Inc., a development state company, operates as an invitro diagnostics company that develops assays or tests to detect cancer. The company's non-invasive diagnostic is based on a patented porphyrin application that preferentially binds to cancerous or aberrant cells extracted from lung sputum samples. It also involves in developing collection protocol and diagnostics for other cancers, including breast, oral, prostate, bladder, colorectal, and cervical. The company has an agreement with the New Mexico Institute of Mining and Technology through the New Mexico Department of Veterans Services for a clinical study for the early detection of lung cancer of the state's veterans. In addition, it has a collaborative agreement with Medical Acoustics, LLC to purchase its Lung Flute as part of the collection protocol in a clinical study. Further, the company has contracts with Quintiles Consulting and Alquest, Inc. who help to guide Biomoda through the FDA approval process. It has a strategic relationship with Obio. The company was founded in 1990 and is headquartered in Albuquerque, New Mexico.

SinoHub, Inc. engages in electronic component sales, outsourced electronics product production and sales, and electronic component supply chain management (SCM) services in the People’s Republic of China and Hong Kong. Its electronic component sales include procurement-fulfillment and electronic component sales to manufacturers. The company’s SCM services include warehousing, delivery, and import/export. It offers SinoHub SCM, a proprietary, Web-based software system that provides order entry with automated price and category checking, order tracking, inventory management information system, shipment information system, payment system, finished orders database, operations results tracking, executive reporting system, shipment tracking, bonded inventory control system, vendor managed inventory, and VAT tracking for recovery on export. The company provides its products to contract manufacturers and design houses, as well as to OEMs and EMS companies. SinoHub, Inc. is headquartered in Shenzhen, the People’s Republic of China.

CEL-SCI Corporation is a biotechnology company. CEL-SCI is involved in the research and development of immunotherapy products for the treatment of cancer and infectious diseases. The Company's core capabilities include: drug discovery, research, development and manufacturing of complex biological substances.

BravoSolution US provides on-demand supply management solutions to companies primarily in the United States and Europe. It offers various supply management software & services in areas, such as program management, spend analysis, eSourcing, contract management, and supplier performance management. The company was formerly known as Verticalnet Inc. and changed its name to BravoSolution US in January 2008. The company was incorporated in 1995 and is based in Malvern, Pennsylvania. As of January 25, 2008, BravoSolution US operates as a subsidiary of BravoSolution SpA.

EarlyBirdCapital, Inc. (“EBC”) is a registered broker-dealer1 and member of the Financial Industry Regulatory Authority, Nasdaq Stock Market, Inc., Municipal Securities Rule Making Board, and Securities Insurance Protection Corporation2. EBC is a boutique investment bank that has developed an expertise in working with smaller capitalization companies, special situation investments and Special Purpose Acquisition Companies (SPACs:tm:), a new concept they pioneered and developed that involves publicly-traded, industry-specific acquisition funds.

ci4net.com is a European economic network, or "Econet". The Company currently owns 50% or more of 26 Internet companies involved in Business-to-Business, Business-to-Consumer, e-Commerce and infrastructure. ci4net.com is focused on adding value at all stages of a company's development via its network. ci4net.com can provide infrastructure technologies, operational and management resources and synergistic access to a network of portfolio companies.

Xceed has been creating top-of-the-line software components for nearly 20 years. Their current product line boasts over 135 professional components, which are used by more than 100,000 professional developers worldwide, including Microsoft in applications such as Visual Studio 2010 and 2012 and Microsoft Office. Their focus is on creating and marketing UI controls that help developers and designers create a compelling user experience (UX) with the Windows Presentation Foundation (WPF), the backbone of LOB solutions. Xceed DataGrid for WPF is their flagship product. Their extensive offering also includes some of the most popular UI controls and data manipulation libraries for .NET (such as Zip and FTP), as well as controls and libraries for Silverlight, Windows Phone, and ActiveX/COM.